IL-8 exerts a pro-tumorigenic activity, by stimulating angiogenesis, recruiting immune suppressive cells into the tumor microenvironment, and promoting epithelial-mesenchymal transition, proliferation and therapy resistance of cancer cells [58, 59]. The gene discussed is CXCL8; the disease is cancer.